Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats

Hypertension

Volumn 31, Issue 3, 1998, Pages 878-884

  Shepherd, Greg ^a   Cam, Margaret C ^a   Sambandam, Nandakumar ^a   Abrahani, Mohammed A ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiomyopathy; Diabetes; Heparin; Lipoprotein lipase; Rats, inbred SHR; Streptozotocin

Indexed keywords

FATTY ACID; HEPARIN; INSULIN; LIPOPROTEIN LIPASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HYPERTENSION; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031886584     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.878     Document Type: Article

References (59)

1. Rodrigues B, Xiang H, McNeill JH. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes. 1988;37:1358-1364.
2. Rodrigues B, Cam MC, McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol. 1995;27: 169-179.
3. Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol. 1993;264:837-844.
4. Chatham JC, Forder JR. Relationship between cardiac function and substrate oxidation in heart of diabetic rats. Am J Physiol. 1997;42:52-58.
5. Tahiliani AG. Myocardial fatty acid metabolism. In: Fozzard HA, ed. The Heart and Cardiovascular System, 2nd ed. New York, NY: Raven Press; 1992:1599-1620.
6. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 1989;320:1060-1068.
7. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A. Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb. 1994;14:1445-1451.
8. Hamosh M, Hamosh P. Lipoprotein lipase: its physiological and clinical significance. Mol Aspects Med. 1983;6:199-289.
9. Levak-Frank S, Radner H, Walsh A, Stollberger R, Knipping G, Hoefler G, Sattler W, Weinstock PH, Breslow JL, Zechner R. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest. 1995;96:976-986.
10. Murthy VK, Bauman MD, Shipp JC. Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes. 1983;32: 718-722.
11. Kenno KA, Severson DL. Lipolysis in isolated myocardial cells from diabetic rat hearts. Am J Physiol 1985;249:1024-1030.
12. Chattopadhayay J, Thompson EW, Schmid HHO. Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats. Lipids. 1990;25:307-310.
13. Rodrigues B, Braun JEA, Spooner M, Severson DL. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rats by plasma lipids. Can J Physiol Pharmacol. 1992;70:1271-1279.
14. Veeraraghavan K, Murthy K, Bauman MD, Shipp J. Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes. 1983;32:718-722.
15. Nomura T, Hagino H, Gotoh M, Iguchi A, Sakamoto N. The effects of streptozotocin diabetes on tissue specific lipase activities in the rat. Lipids. 1984;19:594-599.
16. O'Looney P, Maten MV, Vahouny GV. Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism. J Biol Chem. 1983;258:12994-13001.
17. Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-diabetes on cardiac lipoprotein lipase activity. Diabetes. 1997;46:1346-1353.
18. Chukwuma CJ. Comments on the clinical impact of hypertension in type 1 diabetes. J Diab Comp. 1992;6:197-202.
19. Johnston CI, Cooper ME, Nicholls GM. Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes. J Hypertens. 1992;10:393-397.
20. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980;99:446-458.
21. Rodrigues B, McNeill JH. Cardiac function in spontaneously hypertensive diabetic rats. Am J Physiol. 1986;251:571-580.
22. Sambandam N, Chen X, Cam MC, Rodrigues B. Cardiac lipoprotein lipase in the spontaneously hypertensive rat. Cardiovasc Res. 1997;33: 460-468.
23. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994;26: 1371-1375.
24. Rodrigues B, Cam MC, Kong J, Goyal RK, McNeill JH. Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. Cardiovasc Res. 1997;33:460-468.
25. Jian K, Fok E, Cam MC, Sambandam N, Yao J, Rodrigues B. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin. Can J Physiol Pharmacol. 1996;74:1215-1221.
26. Rodrigues B, Spooner M, Severson DL. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts. Am J Physiol. 1992;262:216-223.
27. Olivecrona T, Bengtsson G, Marklund SE, Lindahl U, Hook M. Heparinlipoprotein lipase interactions. Fed Proc. 1977;1977:36:6-65.
28. Ramirez I, Kryski A, Jr, Ben-Zeev O, Schotz MC, Severson DL. Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart. Biochem J. 1985;23:229-236.
29. Carroll R, Liu L, Severson DL. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts. Biochem J. 1995;310:67-72.
30. Cam MC, McNeill JH. A sensitive radioimmunoassay optimized for reproducible measurement of rat plasma insulin. J Pharmacol Toxicol Methods. 1996;35:111-119.
31. Borensztajn J, Robinson DS. Release of clearing factor lipase by the perfused heart. J Lipid Res. 1970;6:222-227.
32. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin resistance. Atheroscler Thromb. 1991;11:1192-1203.
33. Marotta T, Ferrara LA, DiMarino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F. Factors affecting lipoprotein lipase in hypertensive patients. Metabolism. 1995;44:712-718.
34. Mondon CE, Plato PA, Dall'Aglio E, Sztalryd C, Reaven GM. Mechanism of hypertriglyceridemia in Dahl rat. Hypertension. 1993;21:373-379.
35. Osci LB, Tsika RW, Essig DA. Exercise training has a heparin-like effect on lipoprotein lipase activity in muscle. Can J Physiol Pharmacol. 1992;70: 905-909.
36. Pond CM, Mattacks CA, Sadler D. The effects of exercise and feeding on the activity of lipoprotein lipase in nine different adipose depots of guinea pigs. Int J Biochem. 1992;24:1825-1831.
37. Camps L, Reina M, Lobera M, Vilard S, Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol. 1990;258: 673-681.
38. Blanchette-Mackie EJ, Masuno H, Dwer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol. 1989;256:818-828.
39. Liu G, Olivecrona T. Pulse-chase study on lipoprotein lipase in perfused guinea pig heart. Am J Physiol. 1991;261:2044-2050.
40. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol. 1993;4:187-196.
41. Hultin M, Bengtsson-Olivecrona G, Olivecrona T. Release of lipoprotein lipase to plasma by triacylglycerol emulsions: comparison to the effect of heparin. Biochim Biophys Acta. 1992;1125:97-103.
42. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase: evidence for heparin sulfate proteoglycan-mediated internalization and recycling. J Biol Chem. 1990;265:12880-12886.
43. Saxena U, Klein MG, Goldberg IJ. Transport of lipoprotem lipase across endothelial cells. Proc Natl Acad Sci U S A. 1991;88:2254-2258.
44. + exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol. 1990;258:255-261.
45. + exchange during ischemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res. 1990;24:873-878.
46. Yanagishita M, Hascall VC. Cell surface heparan sulfate proteoglycans. J Biol Chem. 1992;267:9451-9454.
47. Spooner PM, Chernick SS, Garrison MM, Scow RO. Insulin regulation of lipoprotein lipase activity and release in 3T3-L1 adipocytes. J Biol Chem. 1979;254:10021-10029.
48. Chan BL, Lisanti MP, Rodriguez-Boulan E, Saltiel AR. Insulin stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor. Science. 1988;241:1670-1672.
49. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
50. Rodrigues B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 1992;26:913-922.
51. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991;266:8162-8170.
52. Christe ME, Rodgers RL. Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension. 1995;25:235-241.
53. Hennig B, Shasby DM, Fulton AB, Spector AA. Exposure to free fatty acids increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis. 1984;4:489-497.
54. Rutledge JC, Woo MM, Rezai AA, Curtiss LK, Goldberg IJ. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res. 1997;80:819-828.
55. Kubota I, Fukuhara T, Kinoshita M. Permeability of small coronary arteries and myocardial injury in hypertensive diabetic rats. Int J Cardiol. 1990;29: 349-355.
56. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693-707.
57. Rutledge JC, Goldberg IJ. Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LpL increases LDL accumulation in vascular tissue. J Lipid Res. 1994;35:1152-1160.
58. Fernandez-Borja M, Bellido D, Vilella E, Olivecrona G, Vilaro S. Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway. J Lipid Res. 1996;37:464-481.
59. 2+ transients in isolated rabbit cardiomyocytes. J Biol Chem. 1993;268:3767-3775.